ID
45476
Descrição
Principal Investigator: Todd Lencz, PhD, Feinstein Institute for Medical Research, North Shore - LIJ Health System, Manhasset, NY, USA MeSH: Schizophrenia https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000448 Schizophrenia is characterized by high heritability (~80%), yet the identification of susceptibility genes has proven extremely challenging. The Ashkenazi Jewish population, derived from a limited number of founders, may be enriched for a subset of susceptibility alleles, which may also have higher odds ratios than those detected by previous studies. GWAS was conducted in a large Ashkenazi case-control cohort, derived from the Hebrew University Genetic Resource, using the Illumina HumanOmni1-Quad BeadChip.
Link
Palavras-chave
Versões (2)
- 26/10/2022 26/10/2022 - Simon Heim
- 13/12/2022 13/12/2022 - Kristina Keller
Titular dos direitos
Todd Lencz, PhD, Feinstein Institute for Medical Research, North Shore - LIJ Health System, Manhasset, NY, USA
Transferido a
13 de dezembro de 2022
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
dbGaP phs000448 Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort
Subject ID, age, place of subject birth, sex, race, diagnostic instrument, diagnosis, and age at diagnosis of participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject sources, subject source ID, and affection status of participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- Sample ID, subject ID, sample sources, sample source IDs, and sample use variables associated with participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- Subject ID, age, place of subject birth, sex, race, diagnostic instrument, diagnosis, and age at diagnosis of participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- Sample ID, analyte type [DNA], and body site where from samples were collected from participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
Similar models
Subject ID, age, place of subject birth, sex, race, diagnostic instrument, diagnosis, and age at diagnosis of participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject sources, subject source ID, and affection status of participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- Sample ID, subject ID, sample sources, sample source IDs, and sample use variables associated with participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- Subject ID, age, place of subject birth, sex, race, diagnostic instrument, diagnosis, and age at diagnosis of participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- Sample ID, analyte type [DNA], and body site where from samples were collected from participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
C2348585 (UMLS CUI [1,2])